Clinical MR at 3 Tesla: Current Status

被引：30
作者：
Baudendistel K.T. [1 ,2 ]
Heverhagen J.T. [1 ]
Knopp M.V. [1 ]
机构：
[1] Department of Radiology, College of Medicine, Ohio State University, Columbus, OH
[2] Division of Imaging Research, Department of Radiology, Ohio State University, Columbus, OH 43210
来源：
Der Radiologe | 2004年 / 44卷 / 1期
关键词：
3; T-MRI; Contrast mechanisms; High-field-MRI; Whole body imaging;
D O I：
10.1007/s00117-003-0995-3
中图分类号：
学科分类号：
摘要：
Clinical MRI is mostly performed at field strengths up to 1.5 Tesla (T). Recently, approved clinical whole-body MR-systems with a field strength of 3 T became available. Its installation base is more rapidly growing than anticipated. While siting requirements and operation of these systems do not differ substantially from systems with lower field strength, there are differences in practical applications. Imaging applications can use the gain in signal-to-noise for increased spatial resolution or gain in speed. This comes at a trade off in increased sensitivity to field inhomogeneities and changes in relaxation times, which lead to changes in image contrast. The benefit of high field for spectroscopy consists in increased signal-to-noise-ratio and improvement in frequency resolution. The increase in energy deposition necessitates the use of special strategies to reduce the specific absorption rate (SAR). This paper summarizes the current state of MR at 3 T.
引用
收藏
页码：11 / 18
页数：7
相关论文
共 39 条
  • [1] Bernstein M.A., Huston III J., Lin C., Gibbs G.F., Felmlee J.P., High-resolution intracranial and cervical MRA at 3.0 T: Technical considerations and initial experience, Magn Reson Med, 46, pp. 955-962, (2001)
  • [2] Frayne R., Goodyear B.G., Dickhoff P., Lauzon M.L., Sevick R.J., Magnetic resonance imaging at 3.0 Tesla: Challenges and advantages in clinical neurological imaging, Invest Radiol, 38, pp. 385-402, (2003)
  • [3] Hunsche S., Moseley M.E., Stoeter P., Hedehus M., Diffusion-tensor MR imaging at 1.5 and 3.0 T: Initial observations, Radiology, 221, pp. 550-556, (2001)
  • [4] Kangarlu A., Baertlein B.A., Lee R., Ibrahim T., Yang L., Abduljalil A.M., Robitaille P.M., Dielectric resonance phenomena in ultra high field MRI, J Comput Assist Tomogr, 23, pp. 821-831, (1999)
  • [5] Koenig S.H., Brown III R.D., Adams D., Emerson D., Harrison C.G., Magnetic field dependence of 1/T1 of protons in tissue, Invest Radiol, 19, pp. 76-81, (1984)
  • [6] Bottomley P.A., Foster T.H., Argersinger R.E., Pfeifer L.M., A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: Dependence on tissue type, NMR frequency, temperature, species, excision, and age, Med Phys, 11, pp. 425-448, (1984)
  • [7] Mlynarik V., Gruber S., Moser E., Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla, NMR Biomed, 14, pp. 325-331, (2001)
  • [8] Ethofer T., Mader I., Seeger U., Ludolph A., Grodd W., Klose U., Comparison of metabolite T1 relaxation times in different brain regions at 1.5 and 3 Tesla, Proc Intl Soc Mag Reson Med, 11, (2003)
  • [9] Lin C., Bernstein M.A., Huston J., Fein S.B., In-vivo and in-vitro measurements of T1 relaxation at 3.0T, Proc Intl Soc Mag Reson Med, 9, (2001)
  • [10] Brix G., Schulz O., Griebel J., Restriction of high-frequency exposure of patients in MR examinations, Radiologe, 42, pp. 51-59, (2002)
1234